基于加权TOPSIS法的药品不良反应损害救济模式选择研究

中国药物警戒 ›› 2014, Vol. 11 ›› Issue (5): 281-284.

基于加权TOPSIS法的药品不良反应损害救济模式选择研究

陈永法, 辛颖

中国药科大学国际医药商学院,江苏南京 211198

收稿日期:2016-02-03 修回日期:2016-02-03 出版日期:2014-05-08 发布日期:2016-03-02
作者简介:陈永法,男,博士,副教授,医药政策与法规研究。

Research on Mode Selection of Adverse Drug Reaction Injury Relief System by Weighted TOPSIS

CHEN Yong-fa, XIN Ying

School of International Pharmaceutical Business, China Pharmaceutical University, Jiangsu Nanjing 211198, China

Received:2016-02-03 Revised:2016-02-03 Online:2014-05-08 Published:2016-03-02

摘要/Abstract

摘要： 基于利益相关者理论,在问卷调研的基础上,应用加权TOPSIS多目标决策法对目前讨论中的药品不良反应救济模式做出评价和选择,以期为我国药品不良反应救济制度的建立提供参考建议。根据评价结果,基金-保险联动模式排名最高,保险模式次之,基金模式排最后,因此建议我国选择基金-保险联动模式来构建药品不良反应损害救济制度。

关键词: 药品不良反应损害救济, 模式选择, 加权TOPSIS法

Abstract: This article makes evaluation and selection of ADR injury relief modes which were discussed based on stakeholder theory and a survey by weighted TOPSIS multi-objective decision-making method, in order to provide recommendations for the establishment of ADR relief system. According to the results, fund-insurance linkage mode ranked the highest, followed by insurance mode and the fund mode. Therefore fund-insurance linkage mode was recommended to establish ADR relief system.

Key words: adverse drug reaction injury relief, mode selection, weighted TOPSIS

中图分类号:

R951

陈永法, 辛颖. 基于加权TOPSIS法的药品不良反应损害救济模式选择研究[J]. 中国药物警戒, 2014, 11(5): 281-284.

CHEN Yong-fa, XIN Ying. Research on Mode Selection of Adverse Drug Reaction Injury Relief System by Weighted TOPSIS[J]. Chinese Journal of Pharmacovigilance, 2014, 11(5): 281-284.

[1]	殷进军, 王淑伟, 邵姜超, 王冰. 基于加权TOPSIS法的贝伐珠单抗注射液药物利用评价[J]. 中国药物警戒, 2023, 20(12): 1421-1426.
[2]	吴娜, 苏丹, 王海坤, 沈爱宗. 基于加权Topsis-秩和比法评价肿瘤科药品不良反应报告质量[J]. 中国药物警戒, 2023, 20(1): 101-105.
[3]	梁银武, 邹剑. 基于加权TOPSIS法的伏立康唑注射剂药物利用评价[J]. 中国药物警戒, 2018, 15(3): 186-189.